Survey Results

Findings from a National Osteoporosis Foundation (NOF)/Inspire survey

Mission Pharmacal sponsored a survey that was conducted by Inspire with the National Osteoporosis Foundation (NOF) support online community.1

When women with osteoporosis were asked what they liked and disliked about taking their osteoporosis medicine, they spoke out. Swallowing pills or tablets is an issue for more women than one might think.

Some 82% of the survey respondents had been diagnosed with osteoporosis, and 73% had taken or were currently taking osteoporosis medicine in a pill or tablet form.

Their responses paint a clear picture about dosing preferences for osteoporosis medicine.


A total of 331 women participated in the survey; 291 of them had been diagnosed with osteoporosis. The survey was conducted in June and July of 2013.


Talk to your health care professional

If you have difficulty swallowing or would simply prefer liquid instead of a pill or tablet, let your health care professional know. There are alternatives, including BINOSTO® (alendronate sodium) effervescent tablet for oral solution 70 mg.

  • 1. Osteoporosis medication dosing preferences. Survey conducted by Inspire. June 2013.

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Click me, it will be preserved!

If you try to open a new ColorBox while it is already open, it will update itself with the new content.

Updating Content Example:
Click here to load new content